VEGFA and neoplasm: Currently used strategies include tumor oxygenation, oxygen-mimetic radiosensitizers (nimorazole and nitroimidazoles) [59,60], hypoxia-activated prodrugs (tirapazamine) [61] that selectively kill hypoxic cells, HIF signaling inhibitors (PX-478) [62], and VEGF inhibitors (e.g., bevacizumab) [63].